logo
Menu
Innovation Observatory > Reports > Drugs > Cannabidiol (Epidiolex®) for Tuberous Sclerosis Complex – add-on therapy

< Back

Cannabidiol (Epidiolex®) for Tuberous Sclerosis Complex – add-on therapy

Drugs

Neurology and Neurosurgery

December 2017


Cannabidiol is a medicine that is being developed for the treatment of TSC patients who experience inadequately-controlled seizures. It is being developed as an oral medicine to be added to existing treatment options for TSC (‘add-on therapy’). Cannabidiol has a unique chemical structure that makes it prevent or stop seizures and is thought to have cumulative effect. If licensed, cannabidiol will offer an add-on treatment option for patients with TSC who experience inadequately-controlled seizures.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Cannabidiol for Tuberous Sclerosis Complex



 

Connect to the Innovation Observatory

Twitter

Load More Related Posts
Get Alerts